Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Current Alzheimer Research
|
August 15, 2024
Dysregulation of <i>Porphyromonas gingivalis</i> Agmatine Deiminase Expression in Alzheimer's Disease
Asma Hamdi, Sana Baroudi, Alya Gharbi, et al.
Neurogenetics
|
June 28, 2018
Clinical and genetic study of Tunisian families with genetic generalized epilepsy: contribution of CACNA1H and MAST4 genes
Zied Landoulsi, Fatma Laatar, Eric Noé, et al.
La Tunisie Medicale
|
March 12, 2024
Psychiatric disturbances in idiopathic epilepsy
Saloua Mrabet, Syrine Belguith, Imen Kacem, et al.
Journal of Movement Disorders
|
April 22, 2024
The Impact of LRRK2 G2019S on Parkinson's Disease: Clinical Phenotype and Treatment in Tunisian Patients
Guedi Ali Barreh, Ikram Sghaier, Youssef Abida, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape
|
August 2, 2019
Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg disease
Amina Gargouri Berrechid, Mouna Bendjebara, Delphine Bouteiller, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 17, 2020
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19
Imen Kacem, Alya Gharbi, Chahida Harizi, et al.
Multiple Sclerosis and Related Disorders
|
August 9, 2024
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study
Maya Zeineddine, Amal Al-Hajje, Pascale Salameh, et al.
Neurology
|
March 6, 2024
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study
Tim Spelman, Gabrielle Simoneau, Robert Hyde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 26, 2024
Safety and effectiveness of disease-modifying therapies after switching from natalizumab
Maya Zeineddine, Raed Al-Roughani, Samar Farouk Ahmed, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 30, 2022
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
Sifat Sharmin, Charles B Malpas, Izanne Roos, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Current Alzheimer Research
|
August 15, 2024
Dysregulation of <i>Porphyromonas gingivalis</i> Agmatine Deiminase Expression in Alzheimer's Disease
Asma Hamdi, Sana Baroudi, Alya Gharbi, et al.
Neurogenetics
|
June 28, 2018
Clinical and genetic study of Tunisian families with genetic generalized epilepsy: contribution of CACNA1H and MAST4 genes
Zied Landoulsi, Fatma Laatar, Eric Noé, et al.
La Tunisie Medicale
|
March 12, 2024
Psychiatric disturbances in idiopathic epilepsy
Saloua Mrabet, Syrine Belguith, Imen Kacem, et al.
Journal of Movement Disorders
|
April 22, 2024
The Impact of LRRK2 G2019S on Parkinson's Disease: Clinical Phenotype and Treatment in Tunisian Patients
Guedi Ali Barreh, Ikram Sghaier, Youssef Abida, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape
|
August 2, 2019
Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg disease
Amina Gargouri Berrechid, Mouna Bendjebara, Delphine Bouteiller, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 17, 2020
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19
Imen Kacem, Alya Gharbi, Chahida Harizi, et al.
Multiple Sclerosis and Related Disorders
|
August 9, 2024
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study
Maya Zeineddine, Amal Al-Hajje, Pascale Salameh, et al.
Neurology
|
March 6, 2024
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study
Tim Spelman, Gabrielle Simoneau, Robert Hyde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 26, 2024
Safety and effectiveness of disease-modifying therapies after switching from natalizumab
Maya Zeineddine, Raed Al-Roughani, Samar Farouk Ahmed, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 30, 2022
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
Sifat Sharmin, Charles B Malpas, Izanne Roos, et al.
Page
of 6